Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.91 SEK 1.67% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vicore Pharma Holding AB
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Total Equity
kr435m
CAGR 3-Years
-8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Total Equity
kr2B
CAGR 3-Years
5%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Equity
kr661.8m
CAGR 3-Years
32%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Equity
kr13.1B
CAGR 3-Years
32%
CAGR 5-Years
50%
CAGR 10-Years
42%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Equity
kr37.1B
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
23%
BioArctic AB
STO:BIOA B
Total Equity
kr1B
CAGR 3-Years
5%
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
1.9B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
2.94 SEK
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Vicore Pharma Holding AB's Total Equity?
Total Equity
435m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Total Equity amounts to 435m SEK.

What is Vicore Pharma Holding AB's Total Equity growth rate?
Total Equity CAGR 5Y
11%

Over the last year, the Total Equity growth was 44%. The average annual Total Equity growth rates for Vicore Pharma Holding AB have been -8% over the past three years , 11% over the past five years .

Back to Top